Transgene Biotek Share Price

    BSE
    5
    +0.01 (22.22%)
    TRABI • 11 Jul, 2025 | 03:06 PM
    BUY

    1Y Annualised Return

    -50.89%

    3Y Annualised Return

    13.10%

    5Y Annualised Return

    -1.57%

    The current prices are delayed, login or Open Demat Account for live prices.

    Transgene Biotek Stock Performance

    1W Return2.89
    1Y Return-50.89
    Today's Low4.75
    Prev. Close4.99
    Mkt Cap (Cr.)37.81
    1M Return19.38
    3Y Return45.91
    52-Week High10.84
    Open4.99
    PE Ratio0.00
    6M Return21.71
    Today's High5.16
    52-Week Low3.22
    Face Value10

    Transgene Biotek Company background

    Founded in: 1990
    Managing director: K Koteswara Rao
    Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune.Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immunodiagnostic reagents for qualitative and quantitative estimation of biochemical parameters and diagnosis of diseases respectively.Transgene Bioteks products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility costing Rs. 30 crore at the Anrich Industrial Area, Bollaram. TBL is working of four new plants comprising of Oral deliver of proteins and peptides DNA vaccines fusion proteins and bio therapeutics. The new project is funded through preferential offer to Batterymarch Financial Management USA and Other Financial Institutions (FIs).The Company absorbed the transfer of technology from RBB Inc, USA for the manufacture and marketing of Erythropoietin during year 2003. The Scheme of Arrangement for Amalgamation of M/S Saket Biotechnologies Private Limited (SBPL) with the Company was implemented and made effective on 7th February, 2005. In terms of the said Scheme of Amalgamation, 60,60,000 Equity Shares were allotted to the Sharesholders of M/S Saket Biotechnologies Private limited on 27 April 2005.In 201213, the Company started the commercial production of Omega3 DHA (Docosahexaenoic Acid) . It formulated the molecule belonging to a very large global pharma company for undergoing studies at its own chosen facilities in USA during year 202021. Transgene has been developing novel oral and nasal formulations for the delivery of various protein and peptidebased biologicals through oral and intranasal routes. Transgene is focused on developing novel therapies in the areas of Oncology, AutoImmune diseases and new drug delivery technologies, that have the potential to substantially improve the quality of life of patients in areas of unmet medical need.

    As of 11 Jul, 2025, Transgene Biotek share price is ₹5. The stock opened at ₹5 and had closed at ₹5 the previous day. During today’s trading session, Transgene Biotek share price moved between ₹4.75 and ₹5.16, with an average price for the day of ₹4.96. Over the last 52 weeks, the stock has recorded a low of ₹3.22 and a high of ₹10.84. In terms of performance, Transgene Biotek share price has increased by 21.7% over the past six months and has declined by 50.89% over the last year.

    Read More
    Transgene Biotek SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹50,88,136 (-21.72%)
    Daily SIP of 25,000 would have become 50,88,136 in 1 year with a gain of -14,11,863 (-21.72%)
    View details of Market Depth

    Transgene Biotek Fundamental

    Market Cap (in crs)

    37.81

    Face Value

    10

    Turnover (in lacs)

    1.10

    Key Metrics

    Qtr Change %
    53.97% Fall from 52W High
    36.7
    Dividend yield 1yr %
    0

    Transgene Biotek Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Transgene Biotek Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    0.08 Cr
    0.08 Cr
    0.06 Cr
    0.05 Cr
    0.04 Cr
    Transgene Biotek Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    1.04 Cr
    0.42 Cr
    0.23 Cr
    0.3 Cr
    0.44 Cr
    0.18 Cr
    Transgene Biotek Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    -0.71 Cr
    -0.09 Cr
    -0.07 Cr
    0.2 Cr
    -0.27 Cr
    Transgene Biotek Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    -0.68 Cr
    -0.66 Cr
    -6.01 Cr
    -10.4 Cr
    -10.43 Cr
    -10.96 Cr

    Top Mutual Fund Invested in Transgene Biotek

    Promoter
    23.6%
    Public
    76.4%
    Promoter
    23.6%
    Public
    76.4%
    Promoter
    23.6%
    Public
    76.4%
    Promoter
    23.6%
    Public
    76.4%
    Promoter
    23.6%
    Public
    76.4%
    Promoter
    23.6%
    Public
    76.4%

    Transgene Biotek Technical Analysis

    Moving Averages Analysis
    5
    Current Price
    Bullish Moving Averages
    14
    Bearish Moving Averages
    2
    5Day EMA
    4.90
    10Day EMA
    4.80
    12Day EMA
    4.80
    20Day EMA
    4.60
    26Day EMA
    4.60
    50Day EMA
    4.40
    100Day EMA
    4.50
    200Day EMA
    5.10
    5Day SMA
    4.90
    10Day SMA
    4.80
    20Day SMA
    4.60
    30Day SMA
    4.40
    50Day SMA
    4.20
    100Day SMA
    4.00
    150Day SMA
    4.60
    200Day SMA
    5.20
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    22093 Rs
    22093 Rs
    Week Rs
    25833 Rs
    25833 Rs
    Month Rs
    21282 Rs
    21282 Rs
    4.97
    Pivot
    Resistance
    First Resistance
    5.18
    Second Resistance
    5.38
    Third Resistance
    5.59
    Support
    First Support
    4.77
    Second support
    4.56
    Third Support
    4.36
    Relative Strength Index
    79.14
    Money Flow Index
    78.03
    MACD
    0.22
    MACD Signal
    0.18
    Average True Range
    0.26
    Average Directional Index
    21.62
    Rate of Change (21)
    17.69
    Rate of Change (125)
    15.78

    Transgene Biotek Latest News

    26 JUN 2025 | Thursday

    Transgene Biotek Ltd - 526139 - Closure of Trading Window

    30 MAY 2025 | Friday

    Transgene Biotek Ltd - 526139 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    22 MAY 2025 | Thursday

    Transgene Biotek Ltd - 526139 - Integrated Filing (Financial)

    View More

    Transgene Biotek Share Price FAQs

    You can easily buy Transgene Biotek shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Transgene Biotek share price is ₹10.84 and ₹3.22 as of 11/7/2025.

    Please be aware that Transgene Biotek stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.92
    -0.05 (-0.08%)
    135.28
    -1.85 (-1.35%)
    681.80
    -13.80 (-1.98%)
    2,558.70
    -22.30 (-0.86%)
    160.00
    -9.64 (-5.68%)
    381.65
    -3.05 (-0.79%)
    159.84
    -0.82 (-0.51%)
    263.35
    +0.50 (+0.19%)
    409.30
    -4.20 (-1.02%)
    396.85
    -3.05 (-0.76%)
    Top Gainers
    2,519.60
    +111.20 (+4.62%)
    1,835.20
    +25.00 (+1.38%)
    1,173.80
    +9.50 (+0.82%)
    2,220.60
    +16.80 (+0.76%)
    858.85
    +6.00 (+0.70%)
    Top Losers
    3,266.00
    -116.00 (-3.43%)
    3,073.20
    -89.20 (-2.82%)
    8,067.00
    -218.00 (-2.63%)
    258.30
    -6.75 (-2.55%)
    4,218.70
    -102.60 (-2.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -